pando_ruffus 0.1.37

Pando_ruffus is a bioinformatics tool for for exploring and characterising bacterial genome data. Input is paired-end reads and assemblies.

Invivoscribe Expands Ion PGM(TM) NGS Platform Menu: Releases…

Invivoscribe Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields of oncology, personalized molecular diagnostics and personalized molecular medicine , today released three additional CE-marked next-generation sequencing assay kits for in vitro diagnostic use to assist in the diagnosis of B-cell malignancies. Invivoscribe has now commercialized more than 40 CE-IVD assays and bioinformatics packages for capillary electrophoresis and NGS platforms and has recently announced a long-term agreement with Thermo Fisher Scientific to bring regulated IVD assays through the FDA on the Ion PGM Dx System.

Newly discovered breast stem cells wake up when exposed to ovarian hormones

Walter and Eliza Hall Institute researchers have used advanced cellular, bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy. The newly discovered stem cells, which respond to the ‘ovarian hormones’ progesterone and oestrogen, may also be linked to a high-risk form of breast cancer.

Newly discovered breast stem cells wake up when exposed to ovarian hormones

Walter and Eliza Hall Institute researchers have used advanced cellular, bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy. The newly discovered stem cells, which respond to the ‘ovarian hormones’ progesterone and oestrogen, may also be linked to a high-risk form of breast cancer.

buddysuite 1.2.5

The BuddySuite modules are ‘one-stop-shop’ command-line tools for common biological data file manipulations. Formats are detected automatically, conversions are seamless, and you can pipe into or out of the modules to build custom bioinformatics workflows, allowing you to spend more time analyzing your sequences, alignments, and phylogenetic trees, instead of wrangling them.

Research consortium awarded $21 million NIH grant to find ways to…

An international consortium of academic research institutions have been awarded a $21 million grant from the National Institutes of Health to develop better ways to prevent epilepsy in patients who have suffered traumatic brain injuries. The grant will be led by seven principal investigators at five institutions: Albert Einstein College of Medicine, David Geffen School of Medicine at UCLA, Keck School of Medicine at the University of Southern California, University of Melbourne and University of Eastern Finland.

Certara Corporation Releases New Version Of D360, Its…

CertaraA , the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that it has released D360a version 9.0 along with D360 Express, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution used to query multiple cheminformatics and bioinformatics data sources and make informed go/no-go and next step research decisions.

Qiagen N.V. Hereditary And Rare Disease Solution Chosen By Genomics England

HGMD is the leading content knowledgebase for interpretation of genomic data in hereditary and rare diseases, providing a deep resource of expertly curated data from the world’s scientific and clinical literature. The 100,000 Genomes Project will use QIAGEN’s HGMD Online Professional solution, which is part of the QIAGEN Clinical Insight portfolio of solutions for the interpretation of complex genomic data, to support scientists, clinicians and researchers in 13 NHS Genomic Medicine Centres for clinical reporting and interpretation.

European Bioinformatics Institute And Collaborate To Enhance Global…

Red Hat, Inc. , the world’s leading provider of open source solutions, today announced that the European Bioinformatics Institute , part of the European Molecular Biology Laboratory, is using Red Hat OpenStack Platform to deliver the scale and flexibility required to drive its Embassy Cloud project. The goal of Embassy Cloud is to transform the way collaborative research, such as pan-cancer analysis, tackles the world’s toughest biological challenges.

Planning bioinformatics workflows using an expert system.

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Bioinformatic analyses are becoming formidably more complex due to the increasing number of steps required to process the data, as well as the proliferation of methods that can be used in each step.

Using 21st Century Science to Improve Risk-Related Evaluations

Over the last decade, several large-scale United States and international programs have been initiated to incorporate advances in molecular and cellular biology, -omics technologies, analytical methods, bioinformatics, and computational tools and methods into the field of toxicology. Similar efforts are being pursued in the field of exposure science with the goals of obtaining more accurate and complete exposure data on individuals and populations for thousands of chemicals over the lifespan; predicting exposures from use data and chemical-property information; and translating exposures between test systems and humans.

Johns Hopkins researchers helping in search for elusive cancer causing genes

A group of scientists at Johns Hopkins University is studying various bioinformatics methods to discover the ones that help identify the genetic mutations that encourage tumor cells to thrive in an effort to develop drugs to fight the cancer. A group of scientists at Johns Hopkins University is studying various bioinformatics methods to discover the ones that help identify the genetic mutations that encourage tumor cells to thrive in an effort to develop drugs to fight the cancer.